Skip to main content
BioPlus Co., Ltd logo

BioPlus Co., Ltd — Investor Relations & Filings

Ticker · 099430 ISIN · KR7099430001 KO Manufacturing
Open in API
Filings indexed 226 across all filing types
Latest filing 2026-05-14 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 099430

About BioPlus Co., Ltd

https://ubioplus.com/

BioPlus Co., Ltd. is a company that researches, develops, and manufactures biomaterials, with a primary focus on hyaluronic acid (HA) applications. The company's core competency is its proprietary MDM® Technology, which is used to create a diverse product portfolio for the beauty and healthcare industries. Key products include a range of dermal and body fillers, skin boosters, anti-adhesion agents, biomaterial breast implants, and artificial cartilage. The company aims to provide bio-therapy solutions by addressing fundamental cellular-level issues through its advanced technologies.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 96% confidence The document is titled "분기보고서" (Quarterly Report) for the period January 1 2026 to March 31 2026 (the 1st quarter of the 24th business year). It includes detailed company overview, financial data, capital changes, share information, historical events, and other substantive disclosures. It clearly contains the full interim financial report itself rather than merely announcing or summarizing results. Therefore, it should be classified as an Interim / Quarterly Report (Code: IR). Q1 2026
2026-05-14 Korean
전환가액의조정
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the adjustment of the conversion price of convertible bonds, including specific numeric adjustments, dates, and the rationale behind the adjustment. It does not contain financial statements or comprehensive financial performance data. It is a regulatory announcement about a capital structure adjustment related to convertible bonds. The document length is short (2457 characters) and focuses on the adjustment details rather than a full report. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to changes in capital structure through convertible bond conversion price adjustments.
2026-04-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 88% confidence The document is a regulatory notification titled “사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고” (Notification of appointment, dismissal, or mid‐term resignation of outside directors). It provides details on an outside director’s resignation/dismissal (date, name, term, reason) and updated board composition. This clearly corresponds to a board/management change announcement, matching category “Board/Management Information (MANG).”
2026-04-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 95% confidence The document is titled “주식등의 대량보유상황보고서(일반)” (Report on Large Holdings of Stocks) and contains detailed schedules of shareholdings, changes in share numbers, related parties, and regulatory references under the Capital Markets Act. This corresponds exactly to a notification of significant share ownership changes. Hence, it matches the “Major Shareholding Notification” category (Code: MRQ).
2026-04-02 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 93% confidence The document is a formal notification to the Financial Services Commission/Korea Exchange about the appointment (선임), dismissal, or mid‐term resignation of an outside director (사외이사). It provides details on board composition changes, effective date, and biographical information of the new outside director. This clearly matches the definition for Board/Management Information (announcement of changes in the board of directors).
2026-03-30 Korean
기업가치제고계획(자율공시)
Regulatory Filings Classification · 51% confidence The document is a voluntary “기업가치 제고 계획” (corporate value enhancement plan) disclosure required under Korean tax law for high‐dividend companies. It sets out strategic targets, implementation steps, and historical dividend data. It is not announcing a standalone financial report (10‐K/IR), nor a dividend notice per se, nor AGM materials, nor a specific financing update. It is a regulatory disclosure falling under miscellaneous filings. Therefore it should be classified as a general Regulatory Filing (RNS).
2026-03-30 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.